Peptides

Ipamorelin: Growth Hormone Peptide Benefits, Dosage, and What to Expect

The cleanest growth hormone secretagogue — how ipamorelin works, what it does, and how it stacks with CJC-1295

Ipamorelin is a selective growth hormone secretagogue that stimulates the pituitary to release GH without significantly raising cortisol or prolactin — making it one of the preferred GHRP peptides for body composition, recovery, and anti-aging protocols.

Ipamorelin is a pentapeptide (5 amino acids) that selectively stimulates growth hormone release from the anterior pituitary. It was developed in the 1990s and studied initially by Novo Nordisk. Unlike older GHRPs (growth hormone-releasing peptides) like GHRP-2 and GHRP-6, ipamorelin is highly selective — it significantly raises GH without meaningfully increasing cortisol, prolactin, or appetite, making it the preferred GHRP for most clinical protocols.

Ipamorelin is almost always stacked with a GHRH analog (typically CJC-1295 or modified GRF 1-29) to create a dual-action GH pulse: the GHRH increases the amplitude of the pulse, while the GHRP (ipamorelin) increases the frequency and selectivity. This combination produces a more physiologically normal GH release pattern than either compound alone.

Ipamorelin Benefits

Ipamorelin Dosage (Research Reference)

Standard ipamorelin protocols from clinical research and compounding pharmacy guidance:

Ipamorelin vs GHRP-2 and GHRP-6

PeptideGH StimulationCortisol EffectAppetite EffectSelectivity
IpamorelinStrongMinimalMinimalHigh
GHRP-2Very strongModerate increaseModerate increaseLower
GHRP-6StrongModerate increaseStrong increase (hunger)Lower
HexarelinVery strongHigh increaseModerateLowest

Ipamorelin's selectivity is its key advantage. The significant cortisol and prolactin spikes from GHRP-2 and GHRP-6 can blunt the anabolic effect of GH and cause side effects that make those compounds less suitable for long-term anti-aging protocols.

What to Expect: Timeline

Frequently Asked Questions

What is ipamorelin?

Ipamorelin is a synthetic pentapeptide (5 amino acid chain) that acts as a selective growth hormone secretagogue — it stimulates the pituitary gland to release growth hormone in a pulsatile, physiologically normal pattern. It's selective for GH release without significantly raising cortisol, prolactin, or appetite, which distinguishes it from older GHRPs like GHRP-6.

What does ipamorelin do?

Ipamorelin stimulates the pituitary to release growth hormone, which raises IGF-1 levels and produces downstream effects on body composition (lean mass preservation, fat metabolism), tissue repair and recovery, sleep quality, bone density, and the general aging process associated with declining GH (somatopause).

What is the ipamorelin dosage?

Standard ipamorelin dosage in clinical and research protocols is 200–300 mcg per injection, typically administered once daily at bedtime or 2–3 times daily. It's almost always stacked with a GHRH analog like CJC-1295 (100–200 mcg) to produce a synergistic GH pulse. These are research reference ranges, not medical advice.

Does CJC-1295 ipamorelin work?

The CJC-1295 + ipamorelin combination is one of the most evidence-backed growth hormone peptide stacks. CJC-1295 (a GHRH analog) increases the amplitude of GH pulses, while ipamorelin (a GHRP) increases frequency and selectivity. Together they produce a synergistic effect on GH release that exceeds either compound alone, with a cleaner side effect profile than exogenous HGH.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.

Check Where You Stand

Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.

Take the Free Assessment →

Free · Takes 5 minutes · Instant results

Continue Reading

← Back to Peptide Therapy